Cadre director granted 17,393 stock options

Cadre Holdings director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75 per share.

Rhea-AI Filing Summary

Cadre Holdings director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75 per share. The options were granted under Cadre’s 2021 Stock Incentive Plan as equity-based compensation.

These options vest in four installments: options to purchase 4,349 shares vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027. Any unexercised options expire on June 16, 2036.

Insider Trade Summary

Grant/Award: 17,393 shares

Grant/Award 1 txn

Insider QUIGLEY WILLIAM G III

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to purchase)	17,393	$0.00	$0.00

Holdings After Transaction: Stock Option (right to purchase) — 17,393 contracts (Direct)

Footnotes (1)

1. F1. The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

Key Figures

Options granted: 17,393 options Exercise price: $28.75 per share First vesting tranche: 4,349 options +3 more

6 metrics

Options granted 17,393 options Grant of stock options to director on June 16, 2026

Exercise price $28.75 per share Stock option exercise price for Cadre common stock

First vesting tranche 4,349 options Vest and become exercisable on June 30, 2026

Subsequent vesting tranches 4,348 options each Vest on Sept 30, 2026; Dec 31, 2026; Mar 31, 2027

Expiration date June 16, 2036 Option expiration if unexercised

Options held after transaction 17,393 derivatives Total derivative securities following this grant

Key Terms

Stock Option (right to purchase), 2021 Stock Incentive Plan, vest and become exercisable, Common Stock, +1 more

5 terms

Stock Option (right to purchase) financial

"security_title: "Stock Option (right to purchase)""

2021 Stock Incentive Plan financial

"was granted under the Issuer's 2021 Stock Incentive Plan"

vest and become exercisable financial

"will vest and become exercisable on June 30, 2026"

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cadre Holdings (CDRE) report for William G. Quigley III?

Cadre Holdings reported that director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75. This grant is equity compensation under the company’s 2021 Stock Incentive Plan, not an open-market purchase or sale.

What is the vesting schedule of the new Cadre Holdings (CDRE) stock options?

The 17,393 options vest in four tranches: 4,349 options on June 30, 2026, and 4,348 options on each of September 30, 2026, December 31, 2026, and March 31, 2027. Each tranche becomes exercisable as it vests, subject to continued service or plan terms.

What is the exercise price and expiration date of the Cadre Holdings (CDRE) options granted?

The options granted to William G. Quigley III have an exercise price of $28.75 per share and an expiration date of June 16, 2036. They can be exercised only after vesting dates and before expiration, following the company’s 2021 Stock Incentive Plan rules.

Is the Cadre Holdings (CDRE) Form 4 transaction a market buy or sell of shares?

The Form 4 reports a grant of stock options, not a market buy or sell of common shares. It is categorized as a grant or award acquisition under code A, reflecting equity compensation rather than an open-market transaction involving immediate cash outlay.

How many Cadre Holdings (CDRE) derivative securities does William G. Quigley III hold after this grant?

Following this grant, William G. Quigley III holds 17,393 stock options linked to Cadre Holdings common stock. Each option represents the right to purchase one share at $28.75, subject to the specified vesting schedule and the June 16, 2036 expiration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

QUIGLEY WILLIAM G III

(Last) (First) (Middle)

C/O CADRE HOLDINGS, INC.

13386 INTERNATIONAL PKWY

(Street)

JACKSONVILLE FLORIDA 32218

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to purchase)	$28.75	06/16/2026		A		17,393		(1)	06/16/2036	Common Stock	17,393	$0	17,393	D

Explanation of Responses:

1. The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,349 shares of the Issuer's Common Stock will vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares of the Issuer's Common Stock will vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027, respectively.

	/s/ William Quigley	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)